Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Gilbertson, David T ^a   Peng, Yi ^a   Arneson, Thomas J ^a   Dunning, Stephan ^a   Collins, Allan J ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Epidemiology; Epoetin; Hemodialysis

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AFRICAN AMERICAN; AGED; ANTIBIOTIC THERAPY; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLOMERULONEPHRITIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTPATIENT CARE; PERIPHERAL VASCULAR DISEASE; PREDICTIVE VALUE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84873963820     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-44     Document Type: Article

References (13)

1. Identifying persons with diabetes using Medicare claims data. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM, Am J Med Qual 1999 14 270 277 10.1177/106286069901400607 10624032
2. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N, Osman-Malik Y, Frinak S, Besarab A, Am J Kidney Dis 2006 47 644 654 10.1053/j.ajkd.2005.12.025 16564942
3. Erythropoiesis-stimulating agent hyporesponsiveness. Johnson DW, Pollock CA, Macdougall IC, Nephrology (Carlton) 2007 12 321 330 10.1111/j.1440-1797. 2007.00810.x (Pubitemid 47075419)
4. Hyporesponsiveness to recombinant human erythropoietin. Drueke T, Nephrol Dial Transplant 2001 16 Suppl 7 25 28 10.1093/ndt/16.suppl-7.25 11590253 (Pubitemid 33062119)
5. Managing erythropoietin hyporesponsiveness. Kwack C, Balakrishnan VS, Semin Dial 2006 19 146 151 10.1111/j.1525-139X.2006.00141.x 16551293 (Pubitemid 43468648)
6. Hyporesponsiveness to erythropoietin: overview, 1996. Nissenson AR, Perit Dial Int 1996 16 417 420 8863337 (Pubitemid 26336111)
7. Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients. Locatelli F, Andrulli S, Memoli B, Maffei C, Del Vecchio L, Aterini S, De Simone W, Mandalari A, Brunori G, Amato M, Cianciaruso B, Zoccali C, Nephrol Dial Transplant 2006 21 991 998 16384825
8. Cellular mechanism of resistance to erythropoietin. Casadevall N, Nephrol Dial Transplant 1995 10 6 27 30 10.1093/ndt/10.supp6.27 8825429
9. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance. Saudan P, Halabi G, Perneger T, Wasserfallen JB, Wauters JP, Martin PY, J Nephrol 2006 19 91 96 16523432
10. Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Kalantar-Zadeh K, Lee GH, Miller JE, Streja E, Jing J, Robertson JA, Kovesdy CP, Am J Kidney Dis 2009 53 823 834 10.1053/j.ajkd.2008. 12.040 19339087
11. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD, Am J Kidney Dis 2003 42 761 773 10.1016/S0272-6386(03)00915-6 14520627 (Pubitemid 37187377)
12. Correction of anemia with epoetin alfa in chronic kidney disease. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, for the CHOIR Investigators, N Engl J Med 2006 355 2085 2098 10.1056/NEJMoa065485 17108343 (Pubitemid 44749317)
13. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A, for the CREATE Investigators, N Engl J Med 2006 355 2071 2084 10.1056/NEJMoa062276 17108342 (Pubitemid 44749316)